AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
September 2021
Antioxidants
,
Gut health

Research shows link between gut microbiome and flavonoids in improving blood pressure levels

According to new research from Queen’s University, Belfast, a higher intake of flavonoid-rich foods (present in berries, apples, tea, red wine) is associated with a clinically relevant reduction in blood pressure levels, an association that is partially explained by characteristics of the gut microbiome.
Professor Aedín Cassidy, chair and professor in nutrition and preventive medicine at the Institute for Global Food Security at Queen’s, was lead investigator in the study of over 900 adults which has been published in Hypertension, an American Heart Association journal.
Little is known about the relative importance of plant foods and specific constituents called flavonoids on shaping the gut microbiome. There is mounting evidence from population-based studies and clinical trials that a higher intake of flavonoids and flavonoid-rich foods can improve heart health but for the first time this study provides data highlighting the key role of the gut microbiome in explaining the associations between flavonoid-rich foods and blood pressure (BP). Up to 15% of the observed association was explained by the gut microbiome suggesting these microbes play a key role in metabolising flavonoids to enhance their cardioprotective effects.
The study found that higher habitual intakes of flavonoid-rich foods, specifically berries, red wine, apples/pears were associated with clinically relevant reductions in systolic blood pressure and pulse pressure, greater microbial diversity and lower abundance of Parabacteroides.
The researchers comment that these blood pressure lowering effects are achievable with simple changes to the daily diet. Eating ~1.5 servings berries/day was associated with a 4.1 mmHg reduction in systolic BP, and 12% of the association was explained by gut microbiome factors. Drinking ~3 glasses/week of red wine was associated with 3.7 mmHg lower systolic BP levels, of which 15% could be explained by the gut microbiome.
The analysis of habitual flavonoid intake with gut microbiome and blood pressure levels found:
• Study participants who had the highest intake of flavonoid-rich foods, including berries, red wine, apples and pears, had lower systolic blood pressure levels, as well as greater diversity in their gut microbiome than the participants who consumed the lowest levels of flavonoid-rich foods.
• Up to 15.2% of the association between flavonoid-rich foods and systolic blood pressure could be explained by the diversity found in participants’ gut microbiome.
• Eating 80 grams of berries a day was associated with an average reduction in systolic blood pressure levels of 4.1 mm Hg, and about 12% of the association was explained by gut microbiome factors.
• Drinking 250ml of red wine a week, just under three small glasses, was associated with an average of 3.7mm Hg lower systolic blood pressure level of which 15% could be explained by the gut microbiome.
Professor Cassidy said: “Our gut microbiome plays a key role in metabolising flavonoids to enhance their cardioprotective effects, and this study provides evidence to suggest these blood pressure-lowering effects are achievable with simple changes to the daily diet.
“Our findings indicate future trials should look at participants according to metabolic profile in order to more accurately study the roles of metabolism and the gut microbiome in regulating the effects of flavonoids on blood pressure. A better understanding of the highly individual variability of flavonoid metabolism could very well explain why some people have greater cardiovascular protection benefits from flavonoid-rich foods than others.”
The flavonoid–gut microbiome interaction associated with blood pressure highlighted in this paper suggests that research should focus on inter-individual variability in the gut microbiome in mediating the cardiovascular benefits.
Source: Amy Jennings, Manja Koch, Corinna Bang, Andre Franke, Wolfgang Lieb, Aedín Cassidy. Microbial Diversity and Abundance of Parabacteroides Mediate the Associations Between Higher Intake of Flavonoid-Rich Foods and Lower Blood Pressure. Hypertension, 2021;
doi.org/10.1161/hypertensionaha.121.17441
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Rheumatoid arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Latest articles

Alcohol consumption does not modify the polygenic risk score-based genetic risk of breast cancer in postmenopausal women

Drinking pattern and time lag of alcohol consumption with colorectal cancer risk in US men and women

Alcohol consumption and breast and ovarian cancer development

Association between alcohol consumption and risk of type 2 diabetes

Exploring the complex interplay between alcohol consumption and cardiovascular health

Aim Digest

December 2024

January 2025

November 2024

October 2024

August 2024

© Alcohol In Moderation, 2025.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons’ disease& alcohol
  • Rheumatoid arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy